Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

1

Revenue 2017

Humira

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Humira was produced by AbbVie and Eisai.

Cortellis Drugs to Watch in 2020 report

Cortellis Drugs to Watch in 2020 report

The drug must leverage its competitive profile as it will face significant competition from entrenched biological agents (and biosimilar versions), including Humira and Enbrel, as well as direct competition from other

Pharma funding and M&A in 2020

Pharma funding and M&A in 2020 a cool $63bn (which was also notable for putting the world’s best-selling drug Humira under the same roof as Botox).

AbbVie/Allergan merger faces renewed public opposition despite divestments

AbbVie/Allergan merger faces renewed public opposition despite divestments AbbVie. They also highlighted AbbVie’s use of controversial “rebate walls” around its blockbuster immunology products – including Humira and Skyrizi – which the groups say “lead to higher prescription drug prices” and

After FDA refusal, Takeda builds case for subcutaneous Entyvio

After FDA refusal, Takeda builds case for subcutaneous Entyvio AbbVie’s TNF blocker Humira (adalimumab) in a head-to-head trial. ... Analysts at GlobalData have previously suggested that having two formulations of vedolizumab will allow Takeda to compete strongly against well-established ulcerative colitis drugs

20 for 2020 – Five pharma companies to watch

20 for 2020 – Five pharma companies to watch At the moment Humira accounts for nearly two-thirds of AbbVie’s total sales. ... wave of products intended to reduce its reliance on Humira, starting in 2020.

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wilmington Healthcare

A heritage to envy Wilmington Healthcare brings together the data intelligence specialisms of Binley’s, NHiS, Wellards and HSJ to create...

Latest intelligence

Kulveer Singh
Surviving cancer: a new era for patients
Now more than ever, a shift in perspective is needed...
Crisis? No problem!
Issues planning & management for pharma spokespeople, by Andrew Smith...
Are patient recruitment and retention rates rising or falling?
First up, the good news. Over the past seven years, clinical trial recruitment rates have been on the rise....

Infographics